Startups
Edit
BioTrends Research Group
http://bio-trends.com/Last activity: 21.08.2012
Active - Reference to Clarivate
Overview
Location
United States, Pennsylvania, West Whiteland Township
Mentions in press and media 7
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Aug 12, 2011 | Benlysta benchmarks: Progress of the GSK-HGSI lupus treatment so far | “The fundamentals of the Benlysta launch are positive,” said GSK spokeswoman Holly Russell. “The HGS and GSK sales teams have called on 90 percent of the key rheumatology accounts with awareness of Benlysta among rheumatologists at virtuall... |
| Sep 9, 2010 | Four (really 3) ways to control healthcare spending | All three rationalization strategies do have a common dependence upon adoption and utilization of advanced health information technology tools, whether for practice management, sharing of patient records and service information across pract... |
| Sep 9, 2010 | Four ways to control healthcare spending | Labor Day is swiftly receding in the rear view mirror, a potentially transformative (or at least disruptive) mid-year election is only eight weeks away, and Medicare payment regulations for FY 2011 start to go live (acute inpatient hospital... |
| Benlysta benchmarks: Progress of the GSK-HGSI lupus treatment so far | It’s been five months since new lupus drug Benlysta became the first new U.S. Food and Drug Administration-approved lupus treatment in 56 years. Since receiving FDA approval, GlaxoSmithKline (NYSE:GSK) and drug partner Human Genome Sciences... | |
| Relypsa snatches $80M for drug to treat high potassium in kidney disease, diabetes | Name of Company: Relypsa Inc. Industry: Biopharmaceuticals City, State: Santa Clara, California Solution/Product: Patiromer, or RLY5016, is a non-absorbed oral potassium binder being developed for the treatment of hyperkalemia in patients w... | |
| Four (really 3) ways to control healthcare spending | Labor Day is swiftly receding in the rear view mirror, a potentially transformative (or at least disruptive) mid-year election is only eight weeks away, and Medicare payment regulations for FY 2011 start to go live (acute inpatient hospital... |
Reviews 0
FAQ about BioTrends Research Group
What has the press written about BioTrends Research Group?
Parsers VC has collected 7 articles mentioning BioTrends Research Group, among them “Benlysta benchmarks: Progress of the GSK-HGSI lupus treatment so far” (Aug 12, 2011) and “Four (really 3) ways to control healthcare spending” (Sep 9, 2010).
Is BioTrends Research Group still active?
Yes, BioTrends Research Group is active; its latest activity on Parsers VC dates from Aug 21, 2012.